Tag: nuclear medicine market size

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Nuclear Medicine Market Growth in 2025?

The size of the nuclear medicine market has witnessed a fast-paced expansion in the preceding years. The market, standing at $8.93 billion in 2024, is predicted to escalate to $10.2 billion in 2025, with a compound annual growth rate (CAGR) of 14.2%. Factors such as an ageing population, cancer diagnosis and staging, cardiology applications, neurological disorders, and regulatory approvals have considerably contributed to the growth during the historic period.

What Is the Forecast for the Nuclear Medicine Market Size Through 2029?

Expectations are high for quick expansion in the nuclear medicine market over the coming years. The market is projected to soar to $15.77 billion by 2029, with a compound annual growth rate (CAGR) of 11.5%. This growth in the forecasted period can be credited to factors such as personalized medicine, oncology and neurology research, sustainable practices, research and development, coupled with telemedicine services. Notable trends anticipated within this period encompass radioimmunotherapy, hybrid imaging, application of artificial intelligence (AI), emerging radiopharmaceuticals, and advancements in diagnostic imaging.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What are the Key Market Players in Nuclear Medicine Market and How They’re Evolving?

Major companies operating in the nuclear medicine market include Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Medtronic plc, Triad Isotopes Inc., FUJIFILM Holdings Corporation, Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., Global Medical Solutions LLC, Charles River Analytics Inc., Touchlight Genetics Ltd., Numares B.V., Tech-X Corporation, Karyopharm Therapeutics Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC

What Are the Primary Growth Drivers in the Nuclear Medicine Market?

The nuclear medicine market is projected to expand as a result of the rising consistency and prevalence of cardiovascular disease (CVD) and cancer. CVDs refer to disorders of the heart and blood vessels, while cancer is a condition where cells proliferate uncontrollably and invade other areas of the body. The speedier diagnosis of cardiac diseases is facilitated by nuclear cardiac imaging. Cancer treatment may also involve nuclear medicine therapy, which can complement or follow other treatment avenues like surgery and chemotherapy. Consequently, the increased consistency and incidence of CVD and cancer bolster the demand for nuclear medicine. In 2023, 1,958,310 new cancer cases are anticipated in the US, as per data from the American Cancer Society Inc., a non-profit health body in the US. This is up from the 1,918,030 new cases recorded in 2022. Hence, the growth of the nuclear medicine market is being propelled by the escalating consistency and occurrence of cardiovascular diseases and cancer.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

What Are the Leading Segments in the Global Nuclear Medicine Industry?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application

3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras, Radiopharmaceuticals for Imaging, Other Diagnostic Imaging Techniques

2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents, Other Therapeutic Applications

What Are the Key Market Trends in the Nuclear Medicine Industry?

Key players in the nuclear medicine market are channeling their efforts into developing cutting-edge solutions, such as nuclear medicine cyclotrons, with the intent to heighten the production of radiopharmaceuticals and refine diagnostic imaging. Nuclear medicine cyclotrons are specialized forms of particle accelerators that manufacture radioactive isotopes for medical imaging and therapy by directing high-energy particles towards target materials. This process facilitates the production of radiopharmaceuticals utilized in actions like positron emission tomography (PET). GE Healthcare China, a pioneering medical technology establishment based in the US, for instance, launched its initial series of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These exceptional particle accelerators play a vital role in nuclear medicine by enabling the creation of medical isotopes used in molecular imaging and therapeutic applications. The purpose of this initiative is to construct a comprehensive infrastructure for nuclear medicine, thereby boosting capabilities in early disease diagnosis and personalized treatment plans.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

What Is the Regional Outlook for the Nuclear Medicine Market?

North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7485

This Report Delivers Insight On:

1. How big is the nuclear medicine market, and how is it changing globally?

2. Who are the major companies in the nuclear medicine market, and how are they performing?

3. What are the key opportunities and risks in the nuclear medicine market right now?

4. Which products or customer segments are growing the most in the nuclear medicine market?

5. What factors are helping or slowing down the growth of the nuclear medicine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the nuclear medicine industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Nuclear Medicine Market Size Shifted, And What Is the Outlook Through 2034?

The size of the nuclear medicine market has been experiencing swift expansion in the past few years. This market is projected to expand from $8.93 billion in 2024 to reach a value of $10.2 billion in 2025, growing at a compound annual growth rate (CAGR) of 14.2%. Factors contributing to the growth in the historic period include the aging population, cancer detection and staging, cardiology uses, neurological issues, and regulatory approvals.

In the upcoming years, an accelerated growth is anticipated in the size of the nuclear medicine market, escalating to $15.77 billion in 2029 with a compound annual growth rate (CAGR) of 11.5%. Reasons contributing to this growth in the estimate period include advancements in personalized medicine, oncology and neurology studies, sustainable measures, research and development efforts, as well as telemedicine services. The forecast period is also set to witness major trends such as radioimmunotherapy, hybrid imaging, the incorporation of artificial intelligence (AI), the emergence of radiopharmaceuticals, and advancements in diagnostic imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What External and Internal Drivers Are Contributing to the Growth of theNuclear Medicine Market?

The escalating persistence and incidence of cardiovascular disease (CVD) and cancer are projected to fuel the expansion of the nuclear medicine market. Cardiovascular diseases are an array of disorders affecting the heart and blood vessels, while cancer entails the abnormal and uncontrollable growth of cells that invade other parts of the body. The rapid diagnosis of cardiac diseases is facilitated by nuclear cardiac imaging. Furthermore, nuclear medicine therapy offers an approach to cancer treatment that can be employed in conjunction or succession with other therapies like surgery and chemotherapy. Hence, the mounting persistence and frequency of cardiovascular disease and cancer stoke the demand for the nuclear medicine market. As an example, the American Cancer Society Inc., a non-profit health organization based in the US, predicted that 1,958,310 new cancer diagnoses are anticipated in the US in January 2023, marking an increase from over 1,918,030 new cancer cases reported in 2022. Consequently, the escalating persistence and incidence of cardiovascular diseases and cancer are boosting the growth of the nuclear medicine market.

What Segment Types Define the Nuclear Medicine Market Structure?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application

3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras, Radiopharmaceuticals for Imaging, Other Diagnostic Imaging Techniques

2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents, Other Therapeutic Applications

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Nuclear Medicine Market?

North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Nuclear Medicine Market?

Leading firms in the nuclear medicine market are centering their efforts on inventing advanced solutions like nuclear medicine cyclotrons to elevate the creation of radiopharmaceuticals and upgrade diagnostic imaging technologies. Nuclear medicine cyclotrons, which are specific particle accelerators, generate radioactive isotopes for medical imaging and treatment. They accomplish this by directing powerful particles at target substances, leading to the manufacture of radiopharmaceuticals employed in procedures such as positron emission tomography (PET). For example, US-based medical technology firm, GE Healthcare China, introduced its initial series of cyclotrons at the Chengdu Tianfu International Bio-Town on December 1, 2023, following an announcement in January 2024. These modern particle accelerators are vital for nuclear medicine, facilitating the generation of medical isotopes for molecular imaging and therapeutic uses. The step is intended to set up a holistic ecosystem for nuclear medicine, bolstering abilities in early disease diagnosis and individualized treatment.

View the full report here:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

What Is the Definition of the Nuclear Medicine Market?

Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7485

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2334 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Nuclear Medicine Market?

The increasing incidence and prevalence of cardiovascular diseases (CVD) and cancer are expected to fuel the growth of the nuclear medicine market. CVDs, affecting the heart and blood vessels, and cancer, characterized by uncontrolled cell growth, can be diagnosed and treated using nuclear medicine techniques. Nuclear medicine is used to treat cancer, often in combination with other therapies. According to the American Cancer Society, an estimated 1,958,310 new cancer cases are expected to be diagnosed in the U.S. in 2023, a slight increase from 2022. The rising prevalence of CVD and cancer is therefore driving demand for nuclear medicine.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

#How Does the ProjectedNuclear Medicine Market Growth Compare Over the Forecast Period?

The nuclear medicine market has grown rapidly in recent years. It is expected to grow from $8.93 billion in 2024 to $10.2 billion in 2025, with a compound annual growth rate (CAGR) of 14.2%. This growth is attributed to the aging population, increasing cancer diagnoses, applications in cardiology, neurological disorders, and regulatory approvals.

The nuclear medicine market is expected to experience rapid growth, reaching $15.77 billion by 2029 at a CAGR of 11.5%. Growth is attributed to personalized medicine, oncology and neurology research, sustainable practices, research and development, and telemedicine services. Major trends include radioimmunotherapy, hybrid imaging, AI, emerging radiopharmaceuticals, and advancements in diagnostic imaging.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7485

What Are the Key Market Innovations in theNuclear Medicine Market Over the Coming Years?

Companies in the nuclear medicine market are focusing on innovations such as nuclear medicine cyclotrons to improve radiopharmaceutical production and diagnostic imaging. Cyclotrons are specialized accelerators used to produce radioactive isotopes for medical imaging and therapy. For example, in January 2024, GE Healthcare China, a U.S.-based medical tech company, launched its first cyclotrons at Chengdu Tianfu International Bio-Town, aiming to enhance early disease detection and personalized treatment.

Who Are the Top Companies Driving Innovation and Growth in theNuclear Medicine Market?

Major companies operating in the nuclear medicine market include Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Medtronic plc, Triad Isotopes Inc., FUJIFILM Holdings Corporation, Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., Global Medical Solutions LLC, Charles River Analytics Inc., Touchlight Genetics Ltd., Numares B.V., Tech-X Corporation, Karyopharm Therapeutics Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Which Key Market Segments Comprise the Nuclear Medicine Market and Drive Its Revenue Growth?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application

3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras, Radiopharmaceuticals for Imaging, Other Diagnostic Imaging Techniques

2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents, Other Therapeutic Applications

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Which Regions Are Emerging as Leaders in the Nuclear Medicine Market?

North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal Nuclear Medicine Maret 2025, By The Business Research Company:

Research Antibodies and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Metabolomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the nuclear medicine market grown in recent years?

The size of the nuclear medicine market has seen substantial expansion recently. The market, which is projected to escalate from $8.93 billion in 2024 to $10.2 billion in 2025, will experience a compound annual growth rate (CAGR) of 14.2%. Factors such as an aging population, diagnosis and staging of cancer, cardiology applications, neurological disorders, and regulatory approvals have all contributed to this growth in the historic period.

How is the nuclear medicine market size expected to evolve during the forecast period?

The market size for nuclear medicine is projected to experience a swift expansion in the upcoming years, reaching $15.77 billion in 2029 with a compound annual growth rate (CAGR) of 11.5%. This projected increase is due to factors such as personalized healthcare, research in oncology and neurology, sustainable practices, ongoing research and development, and expanded telemedicine services. Key trends expected in this period encompass the use of radioimmunotherapy, hybrid imaging techniques, Artificial Intelligence (AI), progressing radiopharmaceuticals, along with advancements in diagnostic imaging.

Get your nuclear medicine market report here!

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Which key drivers are propelling the nuclear medicine market’s growth?

The escalation in the consistency and occurrence of cardiovascular disease (CVD) and cancer anticipates boosting the expansion of the nuclear medicine market. Cardiovascular diseases encompass a range of heart and blood vessel disorders, while cancer represents an illness in which cells uncontrollably grow and spread throughout the body. Nuclear cardiac imaging possesses the capability to speed up the diagnosis of cardiac diseases. The treatment of cancer may incorporate nuclear medicine therapy, either as an alternative or in conjunction with other therapies like surgery and chemotherapy. Consequently, the rising consistency and incidence of cardiovascular disease and cancer escalates the need for the nuclear medicine market. For instance, data from the American Cancer Society Inc., a non-profit health organization based in the US, reveals an expected diagnosis of 1,958,310 new cancer cases in the US in January 2023, an uptick from more than 1,918,030 new cancer cases in 2022. Thus, the increasing consistency and occurrence of cardiovascular diseases and cancer propel the nuclear medicine market.

What are the market segments in the nuclear medicine industry?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application

3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras, Radiopharmaceuticals for Imaging, Other Diagnostic Imaging Techniques

2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents, Other Therapeutic Applications

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

Which leading companies are shaping the growth of the nuclear medicine market?

Major companies operating in the nuclear medicine market include Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Medtronic plc, Triad Isotopes Inc., FUJIFILM Holdings Corporation, Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., Global Medical Solutions LLC, Charles River Analytics Inc., Touchlight Genetics Ltd., Numares B.V., Tech-X Corporation, Karyopharm Therapeutics Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC

What key trends are currently impacting the nuclear medicine market’s development?

Prominent businesses in the nuclear medicine market are concentrating on creating innovative solutions such as nuclear medicine cyclotrons, to boost the production of radiopharmaceuticals and refine diagnostic imaging capabilities. Nuclear medicine cyclotrons, which are specific particle accelerators, generate radioactive isotopes for medical imaging and therapy through targeting high-energy particles at certain materials. This process enables the creation of radiopharmaceuticals used in procedures like positron emission tomography (PET). As an example of this trend, GE Healthcare China, a US-based medical technology firm, introduced its first set of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are vital for nuclear medicine, facilitating the production of medical isotopes used in molecular imaging and therapeutic applications. This endeavor intends to establish a holistic ecosystem for nuclear medicine, improving capabilities in detecting diseases early and providing personalized treatment.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7485

Which geographic areas are influencing the growth of the nuclear medicine market?

North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Research Antibodies and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Metabolomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Nuclear Medicine Market’s CAGR Through 2034?

The size of the nuclear medicine market has experienced speedy growth in the past few years. Its growth is projected to increase from $8.93 billion in 2024 up to $10.2 billion in 2025, marking a compound annual growth rate (CAGR) of 14.2%. The expansion during the historic phase can be linked to factors like the escalating aging population, advancements in cancer diagnosis and staging, cardiology applications, neurological disorders, and regulatory approvals.

Anticipated to experience a swift expansion in the coming years, the nuclear medicine market is projected to reach a valuation of $15.77 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.5%. This predicted growth can be linked to various factors such as personalized medicine, research in oncology and neurology, sustainable measures, research and development activities, and telemedicine services. Furthermore, the forecast period will witness several significant trends such as radioimmunotherapy, hybrid imaging, the rise of artificial intelligence (AI), emerging radiopharmaceuticals, and advancements in diagnostic imaging.

What Drivers Are Shaping the Growth of the nuclear medicine Market?

The expanding frequency and pervasiveness of cardiovascular disease (CVD) and cancer are predicted to boost the growth of the nuclear medicine market. CVDs refer to a set of disorders impacting the heart and blood vessels, while cancer is characterized by uncontrolled and abnormal cell growth spreading to other parts of the body. Faster diagnosis of cardiac diseases is made possible through nuclear cardiac imaging. In the treatment of cancer, nuclear medicine therapy might be employed in combination with or following other therapeutic modalities, such as surgery or chemotherapy. Consequently, the rising frequency and pervasiveness of CVD and cancer fuel the demand for the nuclear medicine market. For example, in January 2023, the American Cancer Society Inc., a non-profit health organization based in the US, forecasts that there will be 1,958,310 new cancer diagnoses in the US. This represents an increase from the 1,918,030 new cancer cases in 2022. Thus, the escalating frequency and prevalence of cardiovascular diseases and cancer are contributing positively to the growth of the nuclear medicine market.

Get Your Free Sample of the Global Nuclear Medicine Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What Are the Leading Industry Players Dominating the Nuclear Medicine Market?

Major companies operating in the nuclear medicine market include:

• Bracco Imaging S.P.A._x000D_

• Lantheus Medical Imaging Inc._x000D_

• NTP Radioisotopes SOC Ltd._x000D_

• Eckert & Ziegler Group_x000D_

• Jubilant Pharma LLC_x000D_

What Are the Latest Trends Leading to Disruption in the Nuclear Medicine Market?

Leading corporations in the nuclear medicine market are prioritizing the development of groundbreaking solutions such as nuclear medicine cyclotrons, with the goal of increasing radiopharmaceutical production and enhancing diagnostic imaging. Nuclear medicine cyclotrons, a type of specific particle accelerator, generate radioactive isotopes for medical imaging and therapy by propelling high-energy particles towards target materials, thus facilitating the production of radiopharmaceuticals indispensable for positron emission tomography (PET). For example, GE Healthcare China, an American medical tech firm, unveiled their pioneering batch of cyclotrons on December 1, 2023, in Chengdu Tianfu International Bio-Town. They launched it officially in January 2024. These sophisticated particle accelerators are indispensable in nuclear medicine for producing medical isotopes used for molecular imaging and therapeutic uses. The aim of this initiative is to set up a holistic nuclear medicine ecosystem, thereby enriching the early disease detection and personalized treatment capabilities.

Get Instant Access to the Global Nuclear Medicine Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

What Major Market Segments Define the Scope and Growth of the Nuclear Medicine Market?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application

3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras, Radiopharmaceuticals for Imaging, Other Diagnostic Imaging Techniques

2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents, Other Therapeutic Applications

Which Regions Are Significant to the Growth of the Nuclear Medicine Market?

North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Can We Define the Nuclear Medicine Market and Its Key Components?

Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient.

Browse Through More Similar Reports By The Business Research Company:

Research Antibodies and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Metabolomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: